Polygalacturonase
1. Identity and Chemical Classification
Nomenclature and Enzyme Classification
Polygalacturonase is a pectinase — an enzyme that degrades pectin by hydrolyzing the O-glycosyl bonds in pectin's polygalacturonan network, resulting in α-1,4-polygalacturonic residues. The primary and best-characterized form is endo-polygalacturonase. The systematic name for endo-polygalacturonase is (1→4)-α-d-galacturonan glycanohydrolase, and it is classified under Enzyme Commission number EC 3.2.1.15. This enzyme may also be referred to as polygalacturonase pectin depolymerase, pectinase, endopolygalacturonase, pectolase, pectin hydrolase, pectin polygalacturonase, poly-alpha-1,4-galacturonide glycanohydrolase, endogalacturonase, endo-D-galacturonase, or poly(1,4-alpha-D-galacturonide) glycanohydrolase.
Polygalacturonases are further classified into endopolygalacturonase (EC 3.2.1.15) and exopolygalacturonase (EC 3.2.1.67), which hydrolyze the internal and external α-(1,4) glycosidic linkages of pectin, respectively. Within the classification of pectinolytic enzymes more broadly, pectinases are classified into polygalacturonase, pectin lyase, and pectin esterase based on their mode of action. Pectin lyase (EC 4.2.2.10) splits α-(1,4) glycosidic bonds by transelimination, while pectin esterase (EC 3.1.1.11) catalyzes the hydrolysis of the methyl group to produce pectin and methanol.
Physical and Biochemical Properties
In tissues in which it was characterized, the enzyme was optimally active at pH 4.5 to 5.0. The purified enzyme from Aspergillus niger has a pH optimum of 4.0 and stability in the pH range 3.0–11.0. The molecular weight of endo-polygalacturonase reported in papaya was 164,000 Da. The SDS-PAGE profile of pectinases from Aspergillus niger showed that the molecular weight of proteins present in different pectinase preparations varied from 34 to 42 kDa, reflecting the range of forms produced depending on the source organism and preparation method. PG activity isolated from ripe tomato fruit is due to the presence of three structurally and immunologically-related isoforms of PG: PG1, PG2A, and PG2B.
Substrate: Pectin and the Plant Cell Wall
Pectin is a complex high-molecular-weight polysaccharide located in the middle lamella and in the primary cell wall of plants, and is a major constituent of cereals, vegetables, fruits, and fibers. A mixture of pectic substances exists in nature, classified based on the types of modifications in the pectin main chain. The major linear portion of pectin is homogalacturonan, a polymer of α1,4-linked galacturonic acid, which is partially esterified. The branched portion exhibits side chains formed mainly by sugars such as rhamnose, galactose, arabinose, and xylose.
Pectin is one of the three polysaccharides present in the plant cell wall, and it plays a role in maintaining the barrier between the inside and outside environment and gives strength to the plant cell walls. Specifically, pectin in the middle lamella holds neighboring cells together.
2. Natural Sources
Plant Sources
Polygalacturonases are found in bacteria, fungi, plants, and animals. In the plant kingdom, polygalacturonase activity is strongly associated with fruit ripening and softening. Polygalacturonase (PG) has been implicated in the softening of many fruits such as tomatoes, peaches, pears, avocados, and mangoes.
Endo-PG has been isolated from mango, papaya, peach, pear, pepper, and watermelon. While tomatoes are the prime example of high PG activity, this enzyme is also very active in avocado and peach ripening. PG enzymes in peach — two exo-PGs and one endo-PG — become active when the fruit is already soft.
One biochemical change in ripening fruit is the depolymerization and solubilization of cell wall polyuronides by the ripening-induced cell wall-degrading enzyme polygalacturonase (PG). PG activity increases dramatically during the ripening of many fruits, including tomato, and is the primary enzymic activity responsible for cell wall polyuronide degradation during fruit ripening.
Microbial Sources
Industrial production of microbial pectinolytic enzymes is mainly done by filamentous fungi, especially Aspergillus niger. In the literature, the production of pectinases is widely performed by Aspergillus niger, which is the main producer of commercial pectinases and is considered generally recognized as safe (GRAS), allowing the utilization of its metabolites in the food industry. Additionally, the metabolites obtained from A. sojae and A. oryzae are also considered to be of GRAS status.
Various other microbial strains have been evaluated as production hosts in EFSA safety assessments, including Aspergillus tubingensis strain MUCL 55013 (Soufflet Biotechnologies), Trichoderma reesei strain RF6197 (AB Enzymes GmbH), and Talaromyces cellulolyticus strain NITE BP-03478 (Meiji Seika Pharma Co., Ltd.). Orange peel has been identified as the substrate that allows the highest pectinase production by A. niger.
Microbial production of pectinolytic enzymes can be achieved in solid-state fermentation (SSF) or submerged fermentation (SmF), where free and immobilized fungal cells can be used.
3. Traditional and Historical Use
Polygalacturonase itself was not directly isolated or named in ancient remedies; its natural activity was harnessed through the use of pectin-rich fruits and fermented plant extracts in traditional medicine. Cultures from Asia to Europe utilized fruit leathers, jams, and herbal decoctions — often unknowingly benefiting from the enzymatic breakdown of pectin, which promoted digestive health and enhanced nutrient bioavailability. Medicinally, pectin-containing herbal concoctions were commonly prescribed to soothe digestive discomfort, regulate bowel movements, and promote gut health.
An important note on historical context: while the pharmacological use of pectin-rich plant materials has a long history across multiple cultures, the enzyme polygalacturonase as a discrete, identified compound was not part of that historical framework. Its biochemistry was characterized only through modern scientific investigation. Claims of traditional use, where they appear in the literature, refer to the incidental activity of the enzyme within botanical preparations rather than intentional supplementation with isolated polygalacturonase.
The modern history of polygalacturonase as a deliberate commercial tool begins in the food processing industry. Historically, polygalacturonase has been widely utilized in the food industry, particularly in fruit juice clarification and the improvement of texture in various processed foods. Approximately 25% of the enzymes sold in the global market of the food industry are pectinases, where the predominant industrial application is juice and wine clarification. Clarification is achieved by promoting pectin hydrolysis and polysaccharide solubilization, which promotes decreasing viscosity and the agglomeration of suspended solid particles, which can then be removed by filtration or centrifugation.
The use of polygalacturonase in dietary supplements and botanical preparations is a more recent development. In modern times, polygalacturonase is increasingly incorporated into nutritional products and herbal combinations. Its use alongside other enzymes such as cellulase and amylase enhances the breakdown of plant-based ingredients, allowing for more effective release and absorption of phytochemicals and nutrients.
4. Key Constituents and Mechanisms of Action
Enzymatic Mode of Action
The depolymerization implemented through the use of polygalacturonases involves the hydrolysis of the α-1,4-glycosidic bonds between D-galacturonic acid units in the unesterified polygalacturonic backbone.
Exo- and endo-polygalacturonases utilize different hydrolytic modes of action. Endo-polygalacturonases hydrolyze in a random fashion along the polygalacturonan network, resulting in oligogalacturonides. Exo-polygalacturonases hydrolyze at the non-reducing end of the polymer, generating a monosaccharide galacturonic acid.
The rate of hydrolysis is dependent on polysaccharide chain length. Low rates of hydrolysis are associated with very short chains (e.g., digalacturonic acid) and very long chains. Substrate size has an effect on enzyme activity. In general, rate of hydrolysis and substrate affinity increase as the degree of polymerization (DP) increases. However, in most cases, highest Vmax and lowest Km values are observed with substrates of intermediate size.
Interaction with Pectin Methylesterase
The action of pectinesterase eases subsequent depolymerization activity of polygalacturonases towards the degradation of pectin and facilitates further processing of the materials, namely facilitating extraction, maceration, filtration, and clarification. This synergy is important in both food processing and in supplement formulations that include mixed-enzyme complexes.
Production of Oligogalacturonides
Among the enzymes involved in pectin hydrolysis, pectinases, particularly polygalacturonases, play a crucial role in the controlled hydrolysis of cell wall polysaccharides, leading to the formation of oligogalacturonides (OGs). These pectin-derived fragments act as key elicitors of plant defense responses, stimulating innate immunity and enhancing resistance to pathogens by modulating the expression of genes involved in immune responses and inducing the production of defense compounds. The production of OGs is also of interest from a nutritional perspective, as these short-chain fragments may interact with the gastrointestinal environment.
Polygalacturonase-Inhibiting Proteins (PGIPs)
Protein inhibitors of endo-PG activity are known. Polygalacturonase-inhibiting proteins (PGIPs), isolated from cell walls of a number of higher plant sources, have been shown to bind polygalacturonases from fungi, thereby greatly reducing activity. This natural regulatory mechanism is relevant when considering the activity of supplemental polygalacturonase in the presence of intact plant material.
Mechanism of Cell-Wall Disruption and Nutrient Release
Enzyme-assisted extraction employs cellulase and pectinase to liberate bound phytochemicals from complex polysaccharide matrices, as evidenced by β-glucosidase treatment enhancing bioactive aglycone yields from soy isoflavones. Cellulases and pectinases degrade plant fiber matrices, facilitating the release of flavonoids and glycosides. This underpins the rationale for including polygalacturonase in herbal extract preparations and broad-spectrum digestive enzyme supplements.
5. Commercial Preparations and Dosage Forms
In supplemental form, pectinase — which includes polygalacturonase — is typically derived from fungal or bacterial fermentation, commonly from Aspergillus niger. These enzymes include polygalacturonase, pectin lyase, and pectin esterase, all of which help degrade pectic substances into simpler molecules like galacturonic acid. Medicinally, pectinase is often included in digestive enzyme formulas, particularly those aimed at enhancing the breakdown of fiber-rich plant foods.
Commercial pectinases used in the food industry normally contain a mixture of enzymes that split pectic compounds; which traditionally includes PG (polygalacturonase), PL (pectin lyase), and PME (pectin methylesterase). The same multi-enzyme convention typically applies to dietary supplement products. Polygalacturonase is rarely sold as a single isolated enzyme in the supplement market; it is almost always found as a component within broader enzyme blends.
For food manufacturing, endo-polygalacturonase is intended to be used in five food manufacturing processes: fruit and vegetable processing for juice production, fruit and vegetable processing for products other than juice, production of wine and wine vinegar, production of plant extracts as flavouring preparations, and coffee demucilation. These same processes generate the commercially available enzyme preparations that may subsequently be incorporated into supplement formulations.
Dosages Reported in Safety Assessments
Human dosage data specifically for polygalacturonase as a dietary supplement are not established in the peer-reviewed clinical literature. Dosing information comes primarily from toxicological safety evaluations conducted by EFSA for food-processing uses, measured in total organic solids (TOS):
- For fruit and vegetable processing for juice production, fruit and vegetable processing for products other than juice, and wine production, dietary exposure to endo-polygalacturonase from Aspergillus oryzae strain AR-183 was estimated to be up to 0.087 mg TOS/kg body weight per day in European populations.
- Dietary exposure to endo-polygalacturonase from Aspergillus niger strain EPG was estimated to be up to 0.122 mg TOS/kg body weight per day in European populations.
- Exposure to endo-polygalacturonase from Aspergillus tubingensis strain MUCL 55013 was estimated to be up to 7.834 mg TOS/kg body weight per day in European populations, representing the highest exposure scenario across applications including herbal and tea infusion processing.
- Exposure to endo-polygalacturonase from Trichoderma reesei strain AR-414 was estimated to be up to 0.216 mg TOS/kg body weight per day in European populations.
These figures represent incidental dietary exposure through processed foods — not therapeutic doses in supplement contexts. No clinical dose-finding or dose-response trials with isolated polygalacturonase as a standalone supplement were identified in the peer-reviewed literature.
6. Scientific Evidence by Area of Use
6.1 Digestive Health and Enzyme Supplementation
Digestive enzymes can selectively degrade proteins, carbohydrates, and lipids; and their supplementation alongside food may accelerate the breakdown of complex food matrices, facilitate greater nutrient absorption, decrease food sensitivities, and aid in the management of certain disease states.
Proper functioning of the digestive system is imperative to assimilate nutrients, to sustain essential functions in the human body, to increase the bioavailability of nutrients, to minimize the risk of food intolerances, and to reduce the formation of toxins/irritants in the gastrointestinal tract. Incomplete digestion often results in digestive problems such as bloating, diarrhea, stomach pain, and cramps. The aim of one observational study was to compare the use of a gastroprokinetic agent with a full-spectrum digestive enzyme complex from non-animal origin in relieving common digestive complaints. An observational study was performed with 62 volunteers suffering from common digestive problems.
However, it is important to note that this body of clinical evidence refers to multi-enzyme complexes, not to polygalacturonase in isolation. Enzyme supplementation plays an integral role in the management of various digestive disorders, particularly with regard to exocrine pancreatic insufficiency. Safety and efficacy of enzymes derived from microbial species in the treatment of conditions such as malabsorption and lactose intolerance is promising. Polygalacturonase is a frequent but unnamed component in many commercially marketed digestive enzyme blends; no controlled trials specifically testing polygalacturonase alone in digestive outcomes have been identified in the peer-reviewed literature.
Evidence strength: Preliminary and indirect. The available human evidence relates to mixed-enzyme complexes that often include pectinase/polygalacturonase as one component among many. No isolated randomized controlled trials (RCTs) testing polygalacturonase alone in human digestive outcomes have been identified.
6.2 Enhancement of Phytochemical Bioavailability from Herbal Preparations
The use of polygalacturonase alongside other enzymes such as cellulase and amylase enhances the breakdown of plant-based ingredients, allowing for more effective release and absorption of phytochemicals and nutrients.
Enzymatic pretreatment is thought to be a fresh and efficient method for releasing bound compounds and boosting overall yield. Cellulase, amylase, and pectinase are examples of specific enzymes that can be added to extraction processes to improve recuperation by hydrolyzing structural polysaccharides, dissolving the cell wall, and hydrolyzing lipid bodies. The enzyme-assisted extraction (EAE) for phenolic compounds from grape pomace was assessed during wine manufacturing; findings revealed a connection between the level of plant cell wall degradation by enzymes and the output of total phenols.
EAE is particularly useful in the food and pharmaceutical industries, as it reduces the need for harsh solvents and improves bioavailability. This principle underlies the inclusion of polygalacturonase in botanical supplement preparations, where it is intended to help disrupt the plant cell wall matrix during digestion and release bound polyphenols, flavonoids, and other bioactive compounds.
Evidence strength: Preliminary and largely in vitro / ex vivo. The evidence base for polygalacturonase enhancing phytochemical bioavailability from herbal supplements is primarily derived from food-science research on enzyme-assisted extraction. Human clinical trials specifically measuring the effect of orally supplemented polygalacturonase on in vivo phytonutrient bioavailability are absent from the peer-reviewed literature.
6.3 Food Processing and Juice Clarification
This is the most well-established application of polygalacturonase. Pectin present in fruit juices is degraded by pectinases, resulting in viscosity reduction and cluster formation. As a result, the juice becomes clear and more concentrated in flavor and color. This is not a human health claim per se but represents the foundational commercial and industrial evidence base for polygalacturonase activity.
Evidence strength: Strong, for industrial food applications only. This is not a health outcome in the dietary supplement sense; it is a well-validated technological function.
6.4 Oligogalacturonide Production and Potential Gut Microbiota Effects
Polygalacturonases play a crucial role in the controlled hydrolysis of cell wall polysaccharides, leading to the formation of oligogalacturonides (OGs). These pectin-derived fragments act as key elicitors of plant defense responses, stimulating innate immunity and enhancing resistance to pathogens. Research has begun to investigate whether OGs produced in the human gut via enzymatic action on dietary pectin might have prebiotic or immunomodulatory effects in humans.
In a sustainable approach, agricultural by-products rich in pectin, such as citrus peels, apple pomace, or sugar beet pulp, offer an eco-friendly and cost-effective alternative for OG production. The downstream question of whether polygalacturonase supplementation promotes OG formation in the human intestine to a degree relevant for health outcomes has not yet been demonstrated in human clinical trials.
Evidence strength: Very preliminary; primarily in vitro and mechanistic. No human trials specifically investigating OG production from dietary polygalacturonase supplementation have been published in peer-reviewed literature.
6.5 Application in Herbal Extract Manufacture
A significant and increasingly researched application of polygalacturonase is its use during the manufacture of herbal extracts, where it is employed to maximize the yield of active constituents from plant material. The action of endo-polygalacturonase is to degrade galacturonans in the cell wall, thus increasing the yield of the plant products and facilitating the release of bound constituents. In this application, polygalacturonase acts not as the active ingredient in a supplement but as a processing aid that improves the quality and potency of the finished herbal extract. No specific human clinical data exist on whether extracts manufactured using polygalacturonase demonstrate superior clinical outcomes relative to those manufactured without it.
7. Body Systems Associated with Polygalacturonase
- Gastrointestinal System: The enzyme's primary relevance to human health operates in the gastrointestinal tract, where it may contribute to the breakdown of pectin-containing plant cell wall material, potentially easing the digestive processing of high-fiber plant foods. Proper functioning of the digestive system is imperative to assimilate nutrients, sustain essential functions in the human body, increase the bioavailability of nutrients, minimize the risk of food intolerances, and reduce the formation of toxins/irritants in the gastrointestinal tract.
- Gut Microbiota: Galacturonic acid residues and oligogalacturonide fragments produced by enzymatic action on pectin are substrates in the distal intestine. Research on pectin-derived polysaccharides as potential prebiotic compounds is ongoing but not yet directly tied to polygalacturonase supplementation in human trials.
- Systemic Nutrient and Phytonutrient Availability: By disrupting the pectin matrix of plant cell walls, polygalacturonase may assist in the liberation of nutrients and phytochemicals otherwise sequestered within intact cell wall structures. Its use alongside other enzymes such as cellulase and amylase enhances the breakdown of plant-based ingredients, allowing for more effective release and absorption of phytochemicals and nutrients.
8. Safety Considerations
Overall Toxicological Profile
The most comprehensive safety data on polygalacturonase comes from multiple EFSA evaluations of food enzyme preparations. These evaluations consistently examine genotoxicity, systemic toxicity in 90-day rat studies, and allergenicity. Key findings are reported below for several different production strains:
- Genotoxicity tests for the A. oryzae AR-183 preparation did not indicate a safety concern. The systemic toxicity was assessed by a repeated-dose 90-day oral toxicity study in rats. The Panel identified a no-observed-adverse-effect level (NOAEL) of 1,000 mg TOS/kg body weight per day, the highest dose tested, which, when compared with the estimated dietary exposure, resulted in a margin of exposure of at least 11,494.
- Genotoxicity tests for the A. niger EPG preparation did not indicate a safety concern. The systemic toxicity was assessed by a repeated-dose 90-day oral toxicity study in rats. The Panel identified a NOAEL of 1,014 mg TOS/kg body weight per day, the highest dose tested, which resulted in a margin of exposure of at least 8,311.
- The systemic toxicity of the A. luchuensis FLYSC preparation was assessed by a repeated-dose 90-day oral toxicity study in rats. The Panel identified a NOAEL of 800 mg TOS/kg body weight per day, which resulted in a margin of exposure of at least 5,800.
- The systemic toxicity of the A. tubingensis MUCL 55013 preparation was assessed by a repeated-dose 90-day oral toxicity study in rats. The Panel identified a NOAEL of 2,097 mg TOS/kg body weight per day, resulting in a margin of exposure of at least 268.
Across all evaluated preparations, EFSA concluded that these food enzyme preparations do not give rise to safety concerns under their intended conditions of use, given the very large margins between estimated dietary exposure and the NOAELs identified in animal studies.
Allergenicity: A Consistent and Significant Finding
The most consistently identified safety concern across all EFSA evaluations is the potential for allergic reactions, particularly in individuals with pre-existing pollen or food sensitizations. Polygalacturonases are relevant allergens in tree, grass, and weed pollen.
The polygalacturonase Cari p 1 was identified as a food and respiratory allergen in papaya fruit and pollen, respectively. Sensitization to papaya is associated with the pollen food and latex fruit allergy syndrome.
The remaining sequence identity matches found in allergen database searches were allergenic polygalacturonases from pollen of different species: olive tree (Olea europaea), Johnson grass (Sorghum halepense), mountain cedar (Juniperus ashei), Timothy grass (Phleum pratense), maize (Zea mays), Japanese cypress (Chamaecyparis obtusa), Bahia grass (Paspalum notatum), oriental plane tree (Platanus orientalis), and Japanese cedar (Cryptomeria japonica).
The pollen food allergy syndrome, particularly in cedar and juniper pollen-allergic patients, was noted upon consumption of banana and tomato. Polygalacturonases and pectin methylesterases are relevant allergens in tree, grass, and weed pollen.
A search for the similarity of the amino acid sequence of the food enzyme to known allergens found 38 matches, two of which are food allergens. The Panel considered that, under the intended conditions of use, the risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, in particular for individuals sensitized to papaya or maize, but that the risk will not exceed that of consumption of papaya or maize. In addition, oral allergy reactions cannot be excluded in pollen-sensitized individuals.
The Panel noted that oral allergy syndrome (OAS) is associated with sensitization to many pollen allergens, such as that from Johnson grass.
Considerations for Individuals with Specific Sensitivities
A search for the similarity of the amino acid sequence found 14 matches to known allergens, one of which was a food allergen. The Panel considered that the risk of allergic reactions upon dietary exposure cannot be excluded, in particular for individuals sensitized to papaya, but that the risk will not exceed that of consumption of papaya. In addition, oral allergy reactions cannot be excluded in pollen-sensitized individuals.
In summary, the EFSA evaluations consistently identified that individuals with sensitization to pollen allergens from grasses, trees, and weeds — as well as individuals with papaya food allergy — may be at elevated risk of allergic reactions to polygalacturonase preparations derived from microbial fermentation, due to sequence homology between microbially produced polygalacturonases and known pollen and food allergens.
Genetically Modified Production Organisms
Several commercially produced polygalacturonase preparations are derived from genetically modified (GM) fungal strains. EFSA evaluations have repeatedly found that the genetic modifications do not give rise to safety concerns, and the food enzyme is free from viable cells of the production organism and its DNA. The finished enzyme preparation itself is not genetically modified material — it is a protein produced by a GM organism, separated from the organism before use.
9. Limitations of the Evidence Base
A critical assessment of the evidence base for polygalacturonase as a dietary supplement ingredient reveals several important limitations:
- No standalone human clinical trials: No randomized controlled trials, dose-ranging studies, or pharmacokinetic studies have been published in peer-reviewed literature that specifically test the human health effects of orally administered polygalacturonase as a single-entity supplement.
- Multi-enzyme context: When polygalacturonase appears in human studies, it is always as a component of a broad-spectrum enzyme blend, making it impossible to attribute observed effects to polygalacturonase specifically.
- Industrial vs. nutritional evidence: The very large body of evidence on polygalacturonase relates almost entirely to its technological functions in food processing (juice clarification, wine production, coffee demucilation). This evidence does not translate directly into human health endpoints.
- In vitro extrapolation: Claims about enhanced bioavailability of phytonutrients are primarily supported by in vitro enzyme-assisted extraction studies, not by in vivo human absorption studies with supplemental polygalacturonase.
- Stability in the GI tract: As a protein, polygalacturonase is subject to denaturation and proteolytic digestion in the acidic gastric environment, raising questions about how much active enzyme survives transit to the small intestine. This has not been systematically studied in humans for this specific enzyme.
References
Go back